OncoResponse Raises $40.6 Million Series C Financing

NEXT STORY
Delcath Systems, Inc. Announces Positive Preliminary Results from Phase 3 FOCUS Trial of HEPZATO in Patients with Metastatic Ocular Melanoma
PREV STORY
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate

author_avatar
NASDAQ Market News

Animal Vaccine Market Value – US$12.5 Bn By 2028 Says Acumen Research and Consulting Experts

author_avatar
NASDAQ Market News

Karyopharm Announces Dosing of First Patient in Randomized Study Evaluating Low Dose Selinexor in Patients with Severe COVID-19

author_avatar
NASDAQ Market News